Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
Open accessAbstract
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders among school-aged children. It is highly symptomatic and associated with significant impairment. This review examines the role of stimulant medications in the treatment of children and adolescents with ADHD. Published clinical studies that compared methylphenidate- and amfetamine-based stimulants in children and adolescents with ADHD support the therapeutic utility of stimulant treatments, and suggest robust efficacy and acceptable safety outcomes in groups treated with either stimulant. Evidence-based guidelines agree that each patient with ADHD is unique and individual treatment strategies that incorporate both drug and non-drug treatment options should be sought. In seeking to optimize individual response and outcomes to stimulant therapy, important considerations include the selection of stimulant class, the choice of long- or short-acting stimulant formulations, addressing effectively any emergent adverse effects and strategies aimed at enhancing adherence to dosing regimen and persistence on therapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several studies have demonstrated that, although the overall response to MPH and amfetamine is similar, the response to each varies among individual patients, and non-response to one class of psychostimulant does not predict non-response to a second.
“In addition, several studies have demonstrated that, although the overall response to MPH and amfetamine is similar, the response to each varies among individual patients, and non-response to one class of psychostimulant does not predict non-response to a second [32].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069 · see citing works
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771 · see citing works
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346 · see citing works
Tamoxifen for early breast cancer: an overview of the randomised trials
Abe, O., Bartholomeus, S., & Piccart-Gebhart, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,118 · see citing works
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,079 · see citing works
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622 · see citing works
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372 · see citing works
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185 · see citing works
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146 · see citing works
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765 · see citing works
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D. L., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,212 · see citing works
Subgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167 · see citing works
Pocock, S. J., Assmann, S. E., Enos, L. E., & Kasten, L. E. (2002) · Statistics in Medicine · doi:10.1002/sim.1296 · Cited by 1,077 · see citing works
Howell, A. (1998) · PubMed · Cited by 901 · see citing works
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885 · see citing works
Empirically supported psychosocial treatments for attention deficit hyperactivity disorder
Pelham Jr, W. E., Wheeler, T., & Chronis, A. (1998) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2702_6 · Cited by 755 · see citing works
European clinical guidelines for hyperkinetic disorder ? first upgrade
Taylor, E., D�pfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., et al. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1002-x · Cited by 682 · see citing works
Self-citationMechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 626 · see citing works
Kuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623 · see citing works
The Challenge of Subgroup Analyses — Reporting without Distorting
Lagakos, S. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068070 · Cited by 504 · see citing works
Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
Faraone, S. V., & Buitelaar, J. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0054-3 · Cited by 485 · see citing works
PLISZKA, S. R., CRISMON, M. L., HUGHES, C. W., CORNERS, C. K., EMSLIE, G. J., JENSEN, P. S., McCRACKEN, J. T., SWANSON, J. M., & LOPEZ, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215326.51175.eb · Cited by 442 · see citing works
The Royal Australasian College of Physicians
Rosenheim, M. L. (1958) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1958.tb86419.x · Cited by 440 · see citing works
DIAMOND, A. (2005) · Development and Psychopathology · doi:10.1017/s0954579405050388 · Cited by 428 · see citing works
Molecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411 · cited 1× · see citing works
“The aetiology of ADHD is complex, with multiple genetic and non-genetic factors implicated [22, 41].”
BackgroundSmith, T. J., & Khatcheressian, J. L. (2005) · Cited by 401 · see citing works
Faraone, S. V., & Glatt, S. J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04902pur · Cited by 387 · see citing works
Fundamentals of Attention-Deficit/Hyperactivity Disorder: Circuits and Pathways
Arnsten, A. F. T. (2006) · The Primary Care Companion to The Journal of Clinical Psychiatry · Cited by 380 · see citing works
Banaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P., Buitelaar, J., Danckaerts, M., Döpfner, M., Faraone, S. V., Rothenberger, A., et al. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0549-0 · Cited by 375 · see citing works
Self-citationEuropean guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374 · see citing works
Self-citationMechanism of action of methylphenidate: Insights from PET imaging studies
Volkow, N. D., Fowler, J. S., Wang, G., Ding, Y., & Gatley, S. J. (2002) · Journal of Attention Disorders · doi:10.1177/070674370200601s05 · Cited by 353 · see citing works
Amphetamine induces dopamine efflux through a dopamine transporter channel.
Kahlig, K. M., Binda, F., Khoshbouei, H., Blakely, R., McMahon, D. G., Javitch, J., & Galli, A. (2005) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0407737102 · Cited by 303 · see citing works
Efron, D., Jarman, F. C., & Barker, M. J. (1997) · PEDIATRICS · doi:10.1542/peds.100.4.662 · Cited by 301 · see citing works
Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders?
Elia, J., Borcherding, B. G., Rapoport, J. L., & Keysor, C. S. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90126-a · Cited by 294 · see citing works
Brennan, A. R., & Arnsten, A. F. T. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.007 · Cited by 267 · see citing works
Pelham, W. E., Carlson, C. L., Sams, S. E., Vallano, G., Dixon, M. J., & Hoza, B. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.61.3.506 · Cited by 266 · see citing works
Pelham, W. E., Greenslade, K. E., Vodde‐Hamilton, M., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., Guthrie, K. J., Hoover, M. D., & Dahl, R. E. (1990) · PEDIATRICS · doi:10.1542/peds.86.2.226 · Cited by 249 · see citing works
Analysis of randomized comparative clinical trial data for personalized treatment selections
Cai, T., Tian, L., Wong, P. H., & Wei, L. J. (2010) · Biostatistics · doi:10.1093/biostatistics/kxq060 · Cited by 239 · see citing works
Pelham, W. E., Gnagy, E. M., Greiner, A. R., Hoza, B., Hinshaw, S. P., Swanson, J. M., Simpson, S., Shapiro, C. J., Bukstein, O. G., Baron-Myak, C., et al. (2000) · Research on Child and Adolescent Psychopathology · doi:10.1023/a:1005127030251 · Cited by 237 · see citing works
ADHD and the Prefrontal Cortex
Arnsten, A. F. T. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.018 · Cited by 220 · see citing works
Robertson, S. D., Matthies, H. J. G., & Galli, A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8053-4 · Cited by 206 · see citing works
Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
Arnsten, A. F. T. (2006) · PubMed · Cited by 203 · see citing works
Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., Onyango, A. N., Forehand, G. L., Nguyen, A. H., & Waxmonsky, J. G. (1999) · PEDIATRICS · doi:10.1542/peds.103.4.e43 · Cited by 198 · see citing works
Seixas, M., Weiss, M., & Müller, U. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111412095 · Cited by 197 · see citing works
The neurobiological basis of ADHD
Curatolo, P., D'Agati, E., & Moavero, R. (2010) · Italian Journal of Pediatrics · doi:10.1186/1824-7288-36-79 · Cited by 189 · see citing works
Solomon, S. D., Rice, M. M., Jablonski, K. A., Jose, P. O., DOMANSKI, M. J., Sabatine, M. S., Gersh, B. J., Rouleau, J. L., Pfeffer, M. A., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.105.592733 · Cited by 188 · see citing works
Carlson, C. L., Pelham, W. E., Milich, R., & Dixon, J. (1992) · Journal of Abnormal Child Psychology · doi:10.1007/bf00916549 · Cited by 188 · see citing works
Graham, J., & Coghill, D. (2008) · CNS Drugs · doi:10.2165/00023210-200822030-00003 · Cited by 185 · see citing works
Self-citationRemission versus response as the goal of therapy in ADHD: A new standard for the field?
Steele, M., Jensen, P. S., & Quinn, D. M. P. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.11.006 · Cited by 174 · see citing works
Dahabreh, I. J., Terasawa, T., Castaldi, P. J., & Trikalinos, T. A. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-1-201101040-00006 · Cited by 169 · see citing works
Methyiphenidate vs. amphetamine: Comparative review
Arnold, L. E. (2000) · Journal of Attention Disorders · doi:10.1177/108705470000300403 · Cited by 164 · see citing works
Continuity of Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder
Marcus, S. C., Wan, G. J., Kemner, J. E., & Olfson, M. (2005) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.159.6.572 · Cited by 163 · see citing works
Patterns of treatment effects in subsets of patients in clinical trials
Bonetti, M. (2004) · Biostatistics · doi:10.1093/biostatistics/kxh002 · Cited by 160 · see citing works
Patterns of treatment effects in subsets of patients in clinical trials
Bonetti, M. (2004) · Biostatistics · doi:10.1093/biostatistics/5.3.465 · Cited by 152 · see citing works
Advances in understanding and treating ADHD
Antshel, K. M., Hargrave, T. M., Simonescu, M., Kaul, P., Hendricks, K., & Faraone, S. V. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-72 · Cited by 140 · see citing works
Pelham, W. E., Gnagy, E. M., Chronis, A. M., Burrows-MacLean, L., Fabiano, G. A., Onyango, A. N., Meichenbaum, D. L., Williams, A., Aronoff, H. R., & Steiner, R. L. (1999) · PEDIATRICS · doi:10.1542/peds.104.6.1300 · Cited by 138 · see citing works
PLISZKA, S. R., BROWNE, R. G., OLVERA, R. L., & WYNNE, S. K. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200005000-00016 · Cited by 130 · see citing works
Castellanos, F. X., Elia, J., Kruesi, M. J. P., Marsh, W., Gulotta, C. S., Potter, W. Z., Ritchie, G. F., Hamburger, S. D., & Rapoport, J. L. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00077-q · Cited by 129 · see citing works
Evolution of the treatment of attention-deficit/hyperactivity disorder in children: A review
Findling, R. L. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.05.006 · Cited by 129 · see citing works
Section on Allergy and Immunology
(2011) · PEDIATRICS · doi:10.1542/peds.2011-2107b · Cited by 119 · see citing works
Pappadopulos, E., Jensen, P. S., Chait, A. R., Arnold, L. E., Swanson, J. M., Greenhill, L. L., Hechtman, L., Chuang, S., Wells, K. C., Pelham, W., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23ed · Cited by 112 · cited 3× · see citing works
“Despite the carefully managed nature of the Multimodal Treatment Study of Children with ADHD (MTA), saliva assays for MPH revealed that approximately 25 % of 254 patients in the medication arms of the study were nonadherent on 50 % or more of repeated assays, and that barely half (54 %) were adherent at every assay po…”
BackgroundInfluentialSelf-citationthe 311 Study Group, Wigal, S. B., Kollins, S. H., Childress, A. C., & Squires, L. (2009) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-3-17 · Cited by 112 · see citing works
Markowitz, J. S., DeVane, C. L., Pestreich, L. K., Patrick, K. S., & Muniz, R. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.687 · Cited by 109 · see citing works
Faraone, S. V. (2009) · PubMed Central · Cited by 107 · see citing works
Heal, D. J., Smith, S. L., Kulkarni, R. S., & Rowley, H. L. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.03.016 · Cited by 105 · see citing works
Arnold, L. E. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280073008 · Cited by 104 · see citing works
ADHD in Girls: Clinical Comparability of a Research Sample
Sharp, W. S., WALTER, J. M., Marsh, W., Ritchie, G. F., HAMBURGER, S. D., & Castellanos, F. X. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199901000-00018 · Cited by 102 · see citing works
Easton, N., Steward, C., Marshall, F., Fone, K., & Marsden, C. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.07.035 · Cited by 101 · see citing works
Assessment of Adherence Measures with Different Stimulants Among Children and Adolescents
Sanchez, R. J., Crismon, M. L., Barner, J. C., Bettinger, T., & Wilson, J. P. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.7.909 · Cited by 101 · see citing works
Plasma levels of d-amphetamine in hyperactive children: Serial behavior and motor responses
Brown, G. L., Hunt, R. D., Ebert, M. H., Bunney, W. E., & Kopin, I. J. (1979) · Psychopharmacology · doi:10.1007/bf00427126 · Cited by 97 · see citing works
Efron, D., Jarman, F., & Barker, M. (1997) · PEDIATRICS · doi:10.1542/peds.100.6.e6 · Cited by 94 · see citing works
Progress and Promise of Attention-Deficit Hyperactivity Disorder Pharmacogenetics
Froehlich, T. E., McGough, J., & Stein, M. (2010) · CNS Drugs · doi:10.2165/11530290-000000000-00000 · Cited by 91 · see citing works
ADHD in Girls: Clinical Comparability of a Research Sample
Sharp, W. S., Walter, J. M., Marsh, W., Ritchie, G. F., Hamburger, S. D., & Castellanos, F. X. (2002) · Routledge eBooks · doi:10.4324/9780203449523-12 · Cited by 91 · see citing works
Christensen, L., Sasané, R., Hodgkins, P., Harley, C., & Tetali, S. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003673617 · Cited by 86 · see citing works
Self-citationWolraich, M. L., & Doffing, M. (2004) · CNS Drugs · doi:10.2165/00023210-200418040-00004 · Cited by 84 · see citing works
Stimulant drug treatment of hyperactivity: Biochemical correlates
Elia, J., Borcherding, B. G., Potter, W. Z., Mefford, I. N., Rapoport, J. L., & Keysor, C. S. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.118 · Cited by 83 · see citing works
Pharmacokinetics of methylphenidate in hyperkinetic children.
Hungund, B. L., Perel, J. M., Hurwic, M. J., Sverd, J., & Winsberg, B. G. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb01046.x · Cited by 77 · see citing works
Elia, J., Welsh, P. A., Gulotta, C. S., & RAPOPORT, J. L. (1993) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1993.tb01071.x · Cited by 71 · see citing works
Dextroamphetamine and Methylphenidate in the Treatment of Hyperactive/Aggressive Children
Winsberg, B. G., Press, M., Bialer, I., & Kupietz, S. S. (1974) · PEDIATRICS · doi:10.1542/peds.53.2.236 · Cited by 65 · see citing works
Attention-Deficit Hyperactivity Disorder
MAY, D. E., & Kratochvil, C. J. (2009) · Drugs · doi:10.2165/11530540-000000000-00000 · Cited by 62 · see citing works
WILSON, H., Cox, D. J., Merkel, R. L., Moore, M. E., & Coghill, D. (2006) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2006.06.016 · Cited by 55 · see citing works
Self-citationThe Pharmacogenomic Era: Promise for Personalizing Attention Deficit Hyperactivity Disorder Therapy
Stein, M. A., & McGough, J. J. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.009 · Cited by 55 · see citing works
ADHD: Current and Future Therapeutics
Heal, D. J., Smith, S. L., & Findling, R. L. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_125 · Cited by 54 · see citing works
Ramos-Quiroga, J. A., Bosch, R., Castells, X., Valero, S., Nogueira, M., Gómez, N., Yelmo, S., Ferrer, M., Martínez, Y., & Casas, M. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00005 · Cited by 54 · see citing works
Mühlbacher, A. C., Rudolph, I., Lincke, H.-J., & Nübling, M. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-149 · Cited by 52 · see citing works
Borcherding, B. G. (1989) · Neuropsychopharmacology · doi:10.1016/0893-133x(89)90029-8 · Cited by 48 · see citing works
Hermens, D. F., Cooper, N. J., Kohn, M. R., Clarke, S. P., Gordon, E., & Williams, L. M. (2005) · Journal of Integrative Neuroscience · doi:10.1142/s0219635205000653 · Cited by 48 · see citing works
Bellgrove, M. A., Barry, E., Johnson, K. A., Cox, M., Dáibhis, A., Daly, M., Hawi, Z., Lambert, D., Fitzgerald, M., McNicholas, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301637 · Cited by 47 · see citing works
Goodman, D. W. (2010) · PubMed Central · Cited by 36 · see citing works
Multimodal Treatments versus Pharmacotherapy Alone in Children with Psychiatric Disorders
Reeves, G. M., & Anthony, B. J. (2009) · Pediatric Drugs · doi:10.2165/00148581-200911030-00002 · Cited by 35 · see citing works
Faraone, S. V. (2010) · Journal of Attention Disorders · doi:10.1177/1087054710379738 · Cited by 32 · see citing works
Fegert, J. M., Slawik, L., Wermelskirchen, D., Nübling, M., & Mühlbacher, A. C. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.22 · Cited by 29 · see citing works
Misleading subgroup analyses in GISSI
Peto, R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91149-z · Cited by 23 · see citing works
The role of pharmacotherapy and managed care pharmacy interventions in the treatment of ADHD.
Dopheide, J. A. (2009) · PubMed · Cited by 21 · see citing works
Lloyd, A. J., Hodgkins, P., Dewilde, S., Sasané, R., Falconer, S., & Barke, E. S. (2011) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462311000249 · Cited by 19 · see citing works
Self-citationLisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD
Dew, R. E., & Kollins, S. H. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.531009 · Cited by 14 · see citing works
Attention deficit/hyperactivity disorder: pharmacotherapy.
Elia, J. (2005) · PubMed Central · Cited by 9 · see citing works
Tian, L., Cai, T., & Wei, L. (2008) · Biometrics · doi:10.1111/j.1541-0420.2008.01125.x · Cited by 9 · see citing works
Stratifying Subjects for Treatment Selection with Censored Event Time Data from a Comparative Study
Zhao, L., Cai, T., Tian, L., Uno, H., Solomon, S. D., & Wei, L. J. (2010) · Collection of Biostatistics Research Archive · Cited by 8 · see citing works
Clinical Practice Guideline for Patients with Attention Deficit/Hyperactivity Disorder
Carlton, T. G., Donachie, N., Frampton, K. K., Henschen, G., Kumar, P. E., Parrot, L. A., Smith, C. A., Tamil, F. A., Valenti, A. M., & Waxenberg, F. (2014) · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [62]McDonagh M, Peterson K, Dana T, Thakurta S (2007) Drug Class Review on Pharamcologic Treatments for ADHD. http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/adhd/pdfadhd.pdf. Accessed 27 September 2011. Oregon Health and Science University, Portland, Oregon 20480923
Cited by
Sorted by citations
A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)
Luo, Y., Weibman, D., Halperin, J. M., & Li, X. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00042 · Cited by 394 · see citing works
Associations of sleep disturbance with ADHD: implications for treatment
Hvolby, A. (2015) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0151-0 · Cited by 339 · see citing works
Evidence-based pharmacological treatment options for ADHD in children and adolescents
Mechler, K., Banaschewski, T., Hohmann, S., & Häge, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107940 · Cited by 293 · see citing works
Sikirica, V., Lü, M., Greven, P., Zhong, Y., Qin, P., Xie, J., & Gajria, K. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65721 · Cited by 208 · see citing works
Setnik, B., McDonnell, M., Mills, C., Scart‐Grès, C., Robert, P., Dayno, J. M., & Schwartz, J.-C. (2019) · SLEEP · doi:10.1093/sleep/zsz252 · Cited by 189 · see citing works
Onakpoya, I. J., Heneghan, C. J., & Aronson, J. K. (2016) · BMC Medicine · doi:10.1186/s12916-016-0735-y · Cited by 171 · see citing works
Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition
Yu, G., Li, G., & Markowitz, J. S. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0137 · Cited by 102 · see citing works
Huß, M., Duhan, P., Gandhi, P., Chen, C., Spannhuth, C. W., & Kumar, V. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s130444 · Cited by 101 · see citing works
Coghill, D., & Seth, S. (2015) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-015-0083-2 · Cited by 91 · see citing works
Self-citationDittmann, R. W., Cardo, E., Nagy, P., Anderson, C. S., Bloomfield, R., Caballero, B., Higgins, N., Hodgkins, P., Lyne, A., Civil, R., et al. (2013) · CNS Drugs · doi:10.1007/s40263-013-0104-8 · Cited by 88 · see citing works
Self-citationThe female side of pharmacotherapy for ADHD—A systematic literature review
Kok, F. M., Groen, Y., Fuermaier, A. B. M., & Tucha, O. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239257 · Cited by 86 · see citing works
Childress, A. C., & Sallee, F. R. (2014) · CNS Drugs · doi:10.1007/s40263-013-0130-6 · Cited by 86 · see citing works
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
Jaeschke, R. R., Sujkowska, E., & Sowa-Kućma, M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05946-0 · Cited by 90 · see citing works
Toward Precision Medicine in ADHD
Buitelaar, J. K., Bölte, S., Brandeis, D., Caye, A., Christmann, N., Cortese, S., Coghill, D., Faraone, S. V., Franke, B., Gleitz, M., et al. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.900981 · Cited by 79 · see citing works
Self-citationUpdate on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications
Thorpy, M. J., & Bogan, R. (2019) · Sleep Medicine · doi:10.1016/j.sleep.2019.09.001 · Cited by 76 · see citing works
Attention-deficit/hyperactive disorder updates
Kessi, M., Duan, H., Xiong, J., Chen, B., He, F., Yang, L., Ma, Y., Bamgbade, O. A., Peng, J., & Yin, F. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.925049 · Cited by 82 · see citing works
Childress, A. C., Komolova, M., & Sallee, F. R. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1675636 · Cited by 74 · see citing works
Current Pharmacological Treatments for ADHD
Groom, M. J., & Cortese, S. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_330 · Cited by 68 · see citing works
Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy
Ermer, J. C., Pennick, M., & Frick, G. (2016) · Clinical Drug Investigation · doi:10.1007/s40261-015-0354-y · Cited by 67 · see citing works
Cao, M., Martin, E. L., & Li, X.-B. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02536-w · Cited by 67 · see citing works
Nagashima, M., Monden, Y., Dan, I., Dan, H., Tsuzuki, D., Mizutani, T., Kyutoku, Y., Gunji, Y., Hirano, D., Taniguchi, T., et al. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.09.001 · Cited by 60 · see citing works
Possible Cognitive Benefits of Acute Physical Exercise in Children With ADHD
Grassmann, V., Alves, M. V., Galduróz, J. C. F., & Galduróz, J. C. F. (2014) · Journal of Attention Disorders · doi:10.1177/1087054714526041 · Cited by 57 · see citing works
Ding, K.-J., Yang, J.-Z., Reynolds, G., Chen, B., Shao, J., Liu, R.-X., Qian, Q., Liu, H., Yang, R.-X., Wen, J.-F., et al. (2017) · World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1224928 · Cited by 55 · see citing works
Extending therapeutic use of psychostimulants: focus on serotonin-1A receptor.
Haleem, D. (2013) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.07.015 · Cited by 39 · see citing works
Pediatric Psychopharmacology for Treatment of ADHD, Depression, and Anxiety
Southammakosane, C., & Schmitz, K. (2015) · PEDIATRICS · doi:10.1542/peds.2014-1581 · Cited by 45 · see citing works
A clinician’s guide to ADHD treatment options
Mattingly, G. W., Wilson, J. A., & Rostain, A. L. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1354648 · Cited by 45 · see citing works
Soutullo, C. A., Banaschewski, T., Lecendreux, M., Johnson, M., Zuddas, A., Anderson, C. S., Civil, R. H., Higgins, N., Bloomfield, R., Squires, L. A., et al. (2013) · CNS Drugs · doi:10.1007/s40263-013-0086-6 · Cited by 44 · see citing works
Self-citationPredicting methylphenidate response in attention deficit hyperactivity disorder: A preliminary study
Johnston, B. A., Coghill, D., Matthews, K., & Steele, J. D. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548438 · Cited by 44 · see citing works
Self-citationKatzman, M. A., & Sternat, T. (2014) · CNS Drugs · doi:10.1007/s40263-014-0175-1 · Cited by 40 · see citing works
Nagashima, M., Monden, Y., Dan, I., Dan, H., Tsuzuki, D., Mizutani, T., Kyutoku, Y., Gunji, Y., Momoi, M. Y., Watanabe, E., et al. (2014) · Neurophotonics · doi:10.1117/1.nph.1.1.015001 · Cited by 40 · see citing works
Schnorr, I., Siegl, A., Luckhardt, S., Wenz, S., Friedrichsen, H., Jomaa, H. E., Steinmann, A., Kilencz, T., Arteaga-Henríquez, G., Ramos-Sayalero, C., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-023-02729-3 · Cited by 40 · see citing works
Cortese, S., Newcorn, J. H., & Coghill, D. (2021) · CNS Drugs · doi:10.1007/s40263-021-00848-3 · Cited by 35 · see citing works
Self-citationNagashima, M., Monden, Y., Dan, I., Dan, H., Mizutani, T., Tsuzuki, D., Kyutoku, Y., Gunji, Y., Hirano, D., Taniguchi, T., et al. (2014) · Neurophotonics · doi:10.1117/1.nph.1.2.025007 · Cited by 35 · see citing works
Current Investigational Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder
Childress, A. C., & Tran, C. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1147558 · Cited by 33 · see citing works
Genetic Insights Into ADHD Biology
Hayman, V., & Fernandez, T. V. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00251 · Cited by 32 · see citing works
Li, H., Yue, X.-J., Wang, C., Feng, J., Wang, B., & Jia, F. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.599958 · Cited by 29 · see citing works
Amphetamine Use in the Elderly: A Systematic Review of the Literature
Sassi, K. L. M., Rocha, N. P., Colpo, G. D., John, V. P., & Teixeira, A. L. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191010093021 · Cited by 27 · see citing works
Piña, R., Rozas, C., Contreras, D., Hardy, P., Ugarte, G., Zeise, M. L., Rojas, P., & Morales, B. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.040 · Cited by 27 · see citing works
Patterns of long-term ADHD medication use in Australian children
Efron, D., Mulraney, M., Sciberras, E., Hiscock, H., Hearps, S. J. C., & Coghill, D. (2020) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-317997 · Cited by 25 · see citing works
Self-citationParenting Teens With Attention-Deficit/Hyperactivity Disorder
Modesto‐Lowe, V., Chaplin, M., Godsay, V., & Soovajian, V. (2014) · Clinical Pediatrics · doi:10.1177/0009922814540984 · Cited by 24 · see citing works
Gomez-Sanchez, C. I., Carballo, J. J., Riveiro-Alvarez, R., Soto-Insuga, V., Rodrigo, M., Mahillo-Fernandez, I., Abad-Santos, F., Dal-Ré, R., & Ayuso, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-10912-y · Cited by 24 · see citing works
Haleem, D. J., Inam, Q.-U.-A., & Haleem, M. A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.031 · Cited by 23 · see citing works
Li, A., Yeo, K. R., Welty, D. F., & Rong, H. (2017) · Pediatric Drugs · doi:10.1007/s40272-017-0270-0 · Cited by 22 · see citing works
Attention Networks in ADHD Adults after Working Memory Training with a Dual n-Back Task
Dotare, M., Bader, M., Mesrobian, S. K., Asai, Y., Villa, A. E. P., & Lintas, A. (2020) · Brain Sciences · doi:10.3390/brainsci10100715 · Cited by 21 · see citing works
Evidence-based prescribing of medications for ADHD: where are we in 2023?
Cortese, S. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2169604 · Cited by 22 · see citing works
Setyawan, J., Hodgkins, P., Guérin, A., Gauthier, G., Cloutier, M., Wu, E. Q., & Erder, M. H. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.800524 · Cited by 21 · see citing works
Self-citationRaony, Í., Domith, I., Lourenco, M. V., Paes‐de‐Carvalho, R., & Pandolfo, P. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110555 · Cited by 20 · see citing works
Ramtvedt, B. E., Aabech, H. S., & Sundet, K. S. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0114 · Cited by 20 · see citing works
Schawo, S. J., van der Kolk, A., Bouwmans, C. A. M., Annemans, L., Postma, M. J., Buitelaar, J. K., van Agthoven, M., & Roijen, L. H. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0259-x · Cited by 20 · see citing works
Vallejo-Valdivielso, M., de Castro‐Manglano, P., Díez‐Suárez, A., Marín-Méndez, J. J., & Soutullo, C. A. (2019) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/1745017901915010160 · Cited by 20 · see citing works
Mucci, F., Avella, M. T., & Marazziti, D. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190805153610 · Cited by 20 · see citing works
Using task performance to inform treatment planning for youth with ADHD: A systematic review
Molitor, S. J., & Langberg, J. M. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.10.007 · Cited by 16 · see citing works
Wake-Promoting Pharmacotherapy for Psychiatric Disorders
Dell’Osso, B. M., Dobrea, C., Cremaschi, L., Arici, C., & Altamura, A. C. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0524-2 · Cited by 17 · see citing works
Sleep-Related Breathing Disorders in Children—Red Flags in Pediatric Care
Blumer, S., Eli, I., Kaminsky-Kurtz, S., Shreiber-Fridman, Y., Dolev, E., & Emodi‐Perlman, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195570 · Cited by 15 · see citing works
The Pharmacokinetics and Pharmacogenomics of Psychostimulants
Markowitz, J. S., & Melchert, P. W. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.03.003 · Cited by 15 · see citing works
Pillidge, K., Porter, A. J., Young, J. W., & Stanford, S. C. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116642541 · Cited by 15 · see citing works
Soleimani, R., Salehi, Z., Soltanipour, S., Hasandokht, T., & Jalali, M. M. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32613 · Cited by 15 · see citing works
Messineo, L., Norman, D., & Ojile, J. M. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10528 · Cited by 14 · see citing works
Lifetime evolution of ADHD treatment
Mucci, F., Carpita, B., Pagni, G., Vecchia, A. D., Bjedov, S., Pozza, A., & Marazziti, D. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02336-w · Cited by 14 · see citing works
New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development
Heal, D. J., Gosden, J., & Smith, S. L. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_332 · Cited by 14 · see citing works
Translational cognitive systems: focus on attention
Roberts, B. Z., & Young, J. W. (2022) · Emerging Topics in Life Sciences · doi:10.1042/etls20220009 · Cited by 14 · see citing works
Novel Formulations of ADHD Medications: Stimulant Selection and Management
Childress, A. C. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20200032 · Cited by 13 · see citing works
Capuzzi, E., Caldiroli, A., Auxilia, A. M., Borgonovo, R., Capellazzi, M., Clerici, M., & Buoli, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101742 · Cited by 12 · see citing works
Childress, A. C. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.03.001 · Cited by 13 · see citing works
Hodgkins, P., Dittmann, R., Sorooshian, S., & Banaschewski, T. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.31 · Cited by 13 · see citing works
Self-citationLinks between excessive daytime sleepiness and EEG power and activation in two subtypes of ADHD
McCabe, L. E., Johnstone, S. J., Jiang, H., Sun, L., & Zhang, D. (2023) · Biological Psychology · doi:10.1016/j.biopsycho.2023.108504 · Cited by 12 · see citing works
Jain, R., & Stark, J. G. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1218259 · Cited by 12 · see citing works
Tokuda, T., Ikeda, T., Monden, Y., Mizushima, S. G., Inoue, T., Nagashima, M., Shimamura, K., Akari, A., Kobayashi, M. S., Kuroiwa, C., et al. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000418 · Cited by 11 · see citing works
Mazzetti, C., Damatac, C. G., Sprooten, E., ter Huurne, N., Buitelaar, J. K., & Jensen, O. B. (2022) · Psychophysiology · doi:10.1111/psyp.14008 · Cited by 11 · see citing works
Murkett, K., Sikirica, V., Amaia Hervas, G., Newcorn, J. H., Harpin, V., Robertson, B., & Huß, M. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s94158 · Cited by 10 · see citing works
Hondebrink, L., Rietjens, S. J., Hunault, C. C., Pereira, R. R., Kelleci, N., Yasar, G., Ghebreslasie, A., Lo-A-Foe, C., de Vries, I., & Meulenbelt, J. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1004579 · Cited by 10 · see citing works
Bushe, C., Sobanski, E., Coghill, D., Berggren, L., Bruyckere, K. D., & Leppämäki, S. (2016) · CNS Drugs · doi:10.1007/s40263-016-0323-x · Cited by 10 · see citing works
Self-citationGesser‐Edelsburg, A., & Boukai, R. H. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2120-9 · Cited by 10 · see citing works
Selaskowski, B., Staerk, C., Braun, N., Matthies, S., Graf, E., Colla, M., Jacob, C., Sobanski, E., Alm, B., Roesler, M., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.03.049 · Cited by 11 · see citing works
Pozanicline for the treatment of attention-deficit/hyperactivity disorder
Childress, A. C., & Sallee, F. R. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.956078 · Cited by 10 · see citing works
Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD
D’Aiello, B., Vara, S. D., Rossi, P. D., Pretelli, I., Vicari, S., & Menghini, D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031640 · Cited by 10 · see citing works
An updated safety review of the current drugs for managing ADHD in children
Ryst, E., & Childress, A. C. (2023) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2023.2271392 · Cited by 8 · see citing works
Karimi, M., Ghasemzadeh, S., & Fami, F. S. (2025) · Journal of Attention Disorders · doi:10.1177/10870547251387006 · Cited by 6 · see citing works
Ortiz, L. M., O'Malley, N. T., Blum, K., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2023) · Journal of Pediatric Orthopaedics B · doi:10.1097/bpb.0000000000001125 · Cited by 6 · see citing works
Søndergaard, N. R., Nørøxe, K. B., Carlsen, A. H., Randing, S. H., Warrer, P., Thomsen, P. H., & Clausen, L. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2023.0077 · Cited by 6 · see citing works
Reviewing the role of emerging therapies in the ADHD armamentarium
Childress, A. C., Beltran, N., Supnet, C., & Weiss, M. D. (2020) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2020.1846718 · Cited by 7 · see citing works
Woo, H., Park, S. J., Lee, Y., Kwon, G., Gao, Q., Lee, H. E., Ahn, Y. J., Shin, C. Y., Cheong, J. H., & Ryu, J. H. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.06.003 · Cited by 6 · see citing works
Lewandrowski, K., Blum, K., Sharafshah, A., Thanos, K. Z., Thanos, P. K., Zirath, R., Pinhasov, A., Bowirrat, A., Jafari, N., Zeine, F., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15030103 · Cited by 7 · see citing works
D’Aiello, B., Vara, S. D., Rossi, P. D., Vicari, S., & Menghini, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299449 · Cited by 6 · see citing works
Setyawan, J., Hodgkins, P., Guérin, A., Gauthier, G., Cloutier, M., Wu, E. Q., & Erder, M. H. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.832258 · Cited by 5 · see citing works
Self-citationÇevikaslan, A., Parlak, M., Elli̇dağ, H. Y., Kulaksızoğlu, S., & Yılmaz, N. (2021) · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology · doi:10.21307/sjcapp-2021-018 · Cited by 5 · see citing works
Methylphenidate associated vitiligo in a child: A case report
Aksu, G. G., Akdere, P., & Toros, F. (2019) · Asia-Pacific Psychiatry · doi:10.1111/appy.12351 · Cited by 5 · see citing works
Pranjić, M., Peisch, V. D., Vukšić, N., Subedi, S., & Arnett, A. B. (2025) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000001403 · Cited by 5 · see citing works
Cortese, S., Besag, F., Clark, B., Hollis, C. P., Kilgariff, J., Moreno, C., Nicholls, D., Wilkinson, P. O., Woodbury‐Smith, M., & Sharma, A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221140005 · Cited by 4 · see citing works
Childress, A. C., & Burton, S. M. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2103406 · Cited by 4 · see citing works
Reyes-Vasquez, C., Jones, Z., Tang, B., & Dafny, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316628 · Cited by 4 · see citing works
Vertessen, K., Luman, M., Bet, P. M., Bergwerff, C. E., Bottelier, M. A., Stoffelsen, R., Swanson, J. M., Wisse, A., Twisk, J. W. R., & Oosterlaan, J. (2024) · Pediatric Drugs · doi:10.1007/s40272-023-00604-8 · Cited by 4 · see citing works
Parlatini, V., Bellato, A., Roy, S., Murphy, D., & Cortese, S. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0038 · Cited by 4 · see citing works
Caballero, J., Darsey, E., Walters, F., & Belden, H. W. (2017) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s142576 · Cited by 4 · see citing works
Hyperkinetische Störungen im Kindes- und Jugendalter
Stegmann, B., Rexroth, C., Wenzel‐Seifert, K., & Haen, E. (2015) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000339 · Cited by 4 · see citing works
A gyermekkori figyelemzavar és hiperaktivitás kezelése a magyar közfinanszírozott ellátásban
Nagy, P., Bársony, G., Frigyesy, R., Imre, L., Mazzag, B., & Pénzes, M. (2024) · IME - Az egészségügyi vezetők szaklapja · doi:10.53020/ime-2024-206 · Cited by 3 · see citing works
Uebel, H., Dangel, O., Fischer, R., Ruhmann, M., & Huß, M. (2021) · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology · doi:10.21307/sjcapp-2021-009 · Cited by 4 · see citing works
Davidson, F., Rigney, G., Rusak, B., Chambers, C. T., Rajda, M., & Corkum, P. V. (2020) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000866 · Cited by 3 · see citing works
Stimulants: Definition, Pharmacology, Indications, Side Effects, and Treatment Strategies
Steinbuchel, P. H., & Greenhill, L. L. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_324-1 · Cited by 4 · see citing works
Ramtvedt, B. E., Sandvik, L., & Sundet, K. S. (2014) · European Journal of Developmental Psychology · doi:10.1080/17405629.2014.927760 · Cited by 3 · see citing works
- Authors
- Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L.
- Affiliations
- Norgine (United Kingdom) (GB)
- University of Dundee (GB)
- Montreal Children's Hospital (CA)
- Corresponding author
- Hodgkins, Paul
- Venue
- European Child & Adolescent Psychiatry
- Published
- 2012-07-05
- Volume
- 21
- Issue
- 9
- Pages
- 477-492
- ISSN
- 1018-8827 (ISSN-L)
- 1435-165X
- PMC
- PMC3432777
- OpenAlex
- W2117621614
- Cited by
- 147
- References
- 101
- Citations by year
- 2026: 9 · 2025: 6 · 2024: 15 · 2023: 14 · 2022: 16 · 2021: 9 · 2020: 14 · 2019: 11 · 2018: 5 · 2017: 10 · 2016: 9 · 2015: 5 · 2014: 18 · 2013: 6
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- European Child & Adolescent Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- attention deficit hyperactivity disorder, amphetamine, methylphenidate, stimulant medication, children and adolescents, treatment efficacy, drug safety, medication adherence, non-pharmacological treatment, personalized treatment
- MeSH terms
- Amphetamine, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Humans, Methylphenidate, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
